BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Lilly’s Verzenio® (abemaciclib) increases overall survival in HR+, HER2-, high-risk early breast cancer with two years of therapy

  August 28, 2025

   · 

  23 min read
• Press Releases

  Zemcelpro® (UM171 Cell Therapy) receives EC authorization as the first and only cell therapy for blood cancer patients without access to suitable donor cells

  August 28, 2025

   · 

  7 min read
• Press Releases

  Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

  August 28, 2025

   · 

  1 min read
• Press Releases

  Adcendo ApS to Participate in Upcoming September 2025 Investor Conferences

  August 28, 2025

   · 

  1 min read
• Press Releases

  Ocular Therapeutix™ to Participate in September 2025 Investor and Scientific Conferences

  August 28, 2025

   · 

  3 min read
• Press Releases

  Wugen Secures $115 Million to Advance Pivotal Study of First-in-Class Allogeneic CAR-T Therapy, WU-CART-007

  August 28, 2025

   · 

  5 min read
• Press Releases

  TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer

  August 28, 2025

   · 

  3 min read
• Press Releases

  Axsome Therapeutics to Participate in Upcoming September 2025 Investor Conferences

  August 28, 2025

   · 

  5 min read
• Press Releases

  Quell Therapeutics Establishes World-Class Scientific Advisory Board

  August 28, 2025

   · 

  4 min read
• Press Releases

  Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference

  August 28, 2025

   · 

  1 min read